Skip to main content

An overview of radiotracers in nuclear cardiology

This is a preview of subscription content, access via your institution.

References

  1. Braunwald E, Sobel B. Coronary blood flow and myocardial ischemia. In: Braunwald E, editor. Heart disease: A text book of cardiovascular medicine. 4th ed. Philadelphia: WB Saunders; 1992. p. 1161–91.

    Google Scholar 

  2. Johnson P. Autoregulation of blood flow. Circulation Res 1986;58: 483–95.

    Google Scholar 

  3. Pohost GM, Zir LM, Moore LM, et al. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1979;55:294–302.

    Google Scholar 

  4. Zaret BL, Rigo P, Wackers FJT, et al. Myocardial perfusion imaging with Tc-99m tetrofosmin. Comparison to Tl-201 imaging and coronary angiography in a phase III multicenter trial. Circulation 1995;91:313–9.

    PubMed  CAS  Google Scholar 

  5. Maddahi J, Kiat H, Berman DS. Myocardial perfusion imaging with technetium-99m-labeled agents. Am J Cardiol 1991;67:27–34D.

    Article  Google Scholar 

  6. Jain D, Wackers FJT, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin myocardial perfusion imaging agent: Implication for one-day imaging protocol. J Nucl Med 1993;34:1254–9.

    PubMed  CAS  Google Scholar 

  7. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2 bis (bis(2-ethoxyethyl) phosphino) ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30–8.

    PubMed  CAS  Google Scholar 

  8. Nichols AB, Weiss WB, Sciacca RR, Cannon PJ, Blood DK. Relationship between segmental thallium-201 uptake and regional myocardial blood flow in patients with coronary artery disease. Circulation 1983;68:310–20.

    PubMed  CAS  Google Scholar 

  9. DePuey EG, Berman DS, Garcia EV. Cardiac SPECT imaging. Philadelphia: Lippincott-Raven; 1996. p. 159.

    Google Scholar 

  10. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m hexakis-2methoxy-2-methylpropyl-isonitril. Circulation 1988;77:491–8.

    PubMed  CAS  Google Scholar 

  11. Leppo J, Meerdink D. Comparison of the myocardial uptake of a technetiumlabeled isonitrile analog and thallium. Circ Res 1989;65:632–9.

    PubMed  CAS  Google Scholar 

  12. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med 1990;31: 464–72.

    PubMed  CAS  Google Scholar 

  13. Taillefer R, Primeau M, Costi P, Lambert R, Leveille J, Latour Y. Technetium-99-m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: Comparison between initial (1 hour) and delayed (3-hour) postexercise images. J Nucl Med 1991;32:1961–5.

    PubMed  CAS  Google Scholar 

  14. Sinusas AJ, Shi QX, Saltzberg MT, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: Experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664–71.

    PubMed  CAS  Google Scholar 

  15. Selwyn AP, Allan RM, L’Abbate A, et al. Relation between regional myocardial uptake of rubidium-82 and perfusion: Absolute reduction of cation uptake in ischemia. Am J Cardiol 1982;50:112–21.

    PubMed  Article  CAS  Google Scholar 

  16. Tamaki N, Senda M, Yonekura Y, et al. Dynamic positron computed tomography of the heart with a high sensitivity positron camera and nitrogen-13 ammonia. J Nucl Med 1985;26:567–75.

    PubMed  CAS  Google Scholar 

  17. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259–72.

    PubMed  CAS  Google Scholar 

  18. Bergmann SR, Fox KAA, Rand AL, et al. Quantification of regional myocardial blood flow in vivo with 0-15 water. Circulation 1984; 70:724–33.

    PubMed  CAS  Google Scholar 

  19. Veerkamp JH, van Moerkerk HT. Fatty acid-binding protein and its relation to fatty acid oxidation. Mol Cell Biochem 1993;123:101–6.

    PubMed  Article  CAS  Google Scholar 

  20. Schelbert HR, Henze E, Schon H, et al. Carbon-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. Am Heart J 1983;105:492–504.

    PubMed  Article  CAS  Google Scholar 

  21. Ratib O, Phelps ME, Huang SC, et al. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med 1982;23:577–86.

    PubMed  CAS  Google Scholar 

  22. Kaul S, Boucher CA, Newell JB, et al. Determination of the quantitative thallium imaging variables that optimize detection of coronary artery disease. J Am Coll Cardiol 1986;7:527–37.

    PubMed  CAS  Google Scholar 

  23. Christian TF, Miller TD, Bailey KR, Gibbons RJ. Noninvasive identification of severe coronary artery disease using exercise tomographic thallium-201 imaging. Am J Cardiol 1992;70:14–20.

    PubMed  Article  CAS  Google Scholar 

  24. Zaret BL, Wackers FJT, Soufer R. Nuclear cardiology. In: Braunwald E, editor. Heart disease: A textbook of cardiovascular medicine. 4th ed. Vol. 1. Philadelphia: W.B. Saunders; 1992. p. 276–311.

    Google Scholar 

  25. Kahn JK, McGhie I, Akers MS, et al. Quantitative rotational tomography with Tl-201 and Tc-99m 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989;79:1282–93.

    PubMed  CAS  Google Scholar 

  26. Sridhara BS, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium-201 in coronary artery disease. Am J Cardiol 1993;72:1015–9.

    PubMed  Article  CAS  Google Scholar 

  27. Dilsizian V, Rocco TP, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. I. Relation to severity of coronary artery stenosis. J Am Coll Cardiol 1989;14:1673–7.

    PubMed  Article  CAS  Google Scholar 

  28. Bonow RO, Dilsizian V. Thallium-201 for assessing myocardial viability. Semin Nucl Med 1991;21:230–41.

    PubMed  Article  CAS  Google Scholar 

  29. Holman ML, Moore SC, Shulkin PM, Kirsch CM, English RJ, Hill TC. Quantification of perfused myocardial mass through thallium-201 and emission computed tomography. Invest Radiol 1983;4:322–6.

    Google Scholar 

  30. Udelson EJ, Coleman PS, Metheral J, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 1994; 89:2552–61.

    PubMed  CAS  Google Scholar 

  31. Sciagrà R, Santoro GM, Bisi B, Pedenovi P, Fazzini PF, Pupi A. Restredistribution thallium-201 SPECT to detect myocardial viability. J Nucl Med 1998;39:385–90.

    Google Scholar 

  32. Pace L, Perrone Filardi P, Mainenti PP, et al. Identification of viable myocardium in patients with chronic coronary artery disease using restredistribution thallium-201 tomography: Optimal image analysis. J Nucl Med 1998;39:1869–74.

    PubMed  CAS  Google Scholar 

  33. Cuocolo A, Acampa W, Nicolai E, et al. Quantitative thallium-201 and technetium-99m sestamibi tomography at rest in detection of myocardial viability and prediction of improvement in left ventricular function after coronary revascularization in patients with chronic ischemic left ventricular dysfunction. J Nucl Cardiol 2000;7:8–15.

    PubMed  Article  CAS  Google Scholar 

  34. Kayden DS, Mattera JA, Zaret BL, Wackers FJTh. Demonstration of reperfusion after thrombolysis with technetium-99m isonitrile myocardial imaging. J Nucl Med 1988;29:1865–7.

    PubMed  CAS  Google Scholar 

  35. Brown KA, Boucher CA, Okada RG, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994–1001.

    PubMed  CAS  Google Scholar 

  36. Ladenhein ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464–71.

    Google Scholar 

  37. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserlzeben V, Cave V. Independent and incremental prognostic value of exercise singlephoton emission computed tomography (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665–70.

    PubMed  CAS  Article  Google Scholar 

  38. Petretta M, Cuocolo A, Capinelli A, et al. Prognostic value of myocardial hypoperfusion indexes in patients with suspected or known coronary artery disease. J Nucl Cardiol 1994;1:325–37.

    PubMed  Article  CAS  Google Scholar 

  39. Fagan LF, Shaw L, Kong BA, Caralis DG, Wiens RD, Chaitman BR. Prognostic value of exercise thallium scintigraphy in patients with good exercise tolerance and a normal or abnormal exercise electrocardiogram and suspected or confirmed coronary artery disease. Am J Cardiol 1992;69:607–11.

    PubMed  Article  Google Scholar 

  40. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: A basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639–47.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Alberto Cuocolo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Acampa, W., Di Benedetto, C. & Cuocolo, A. An overview of radiotracers in nuclear cardiology. J Nucl Cardiol 7, 701–707 (2000). https://doi.org/10.1067/mnc.2000.109969

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1067/mnc.2000.109969

Keywords

  • Myocardial Perfusion
  • Thallium
  • Myocardial Perfusion Imaging
  • Myocardial Blood Flow
  • Nuclear Cardiology